![Matthew Henn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Henn
President chez
SERES THERAPEUTICS, INC.
Fortune : 57 374 $ au 31/05/2026
Profil
Matthew R.
Henn is currently Director at The Microbiome Therapeutics Innovation Group and President & Chief Scientific Officer at Seres Therapeutics, Inc. Former roles include Director at Viral Genomics, Inc. and Director-Viral Genomics at The Broad Institute, Inc. from 2005 to 2012.
Education includes a doctorate from the University of California, Berkeley and an undergraduate degree from the University of New Hampshire.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/05/2026 | 7 838 ( 0,08% ) | 57 374 $ | 31/05/2026 |
Postes actifs de Matthew Henn
| Sociétés | Poste | Début |
|---|---|---|
| SERES THERAPEUTICS, INC. | President | 02/03/2026 |
Anciens postes connus de Matthew Henn
| Sociétés | Poste | Fin |
|---|---|---|
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Corporate Officer/Principal | 01/06/2012 |
Viral Genomics, Inc. | Directeur/Membre du Conseil | - |
Formation de Matthew Henn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
27
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New Hampshire
 University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viral Genomics, Inc. | |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Health Technology |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
